It is a known target gene of TGFβ in colon cancer [11], and has been associated with activin-induced growth arrest in plasmacytic and breast cancer cells [12], [13], but effects of activin on p21 in colon cancer cells as well as downstream consequences have not been assessed. Here, CDKN1A is linked to colonic neoplasm.